Crafting a Cure for Diabetic Neuropathic Pain, Molecule by Molecule (Published by NIH)
A team of scientists at Knopp Biosciences LLC is innovating treatments to manage neuropathic pain by aiming at its source — hyperactive nerve cells.
A team of scientists at Knopp Biosciences LLC is innovating treatments to manage neuropathic pain by aiming at its source — hyperactive nerve cells.
Knopp’s pipeline consists of investigational drug products that have not been approved by the U.S. Food and Drug Administration. These investigational drug products are undergoing clinical study to verify their safety and effectiveness.